
Dimethyl fumarate
Dimethyl Fumarate Gedeon Richter is a medicine that contains the active substance dimethyl fumarate.
Multiple sclerosis is a chronic disease that damages the central nervous system (CNS), including the brain and spinal cord. Relapsing-remitting multiple sclerosis is characterized by recurring, periodic exacerbations of neurological symptoms (called relapses). Symptoms vary among patients but usually include gait and balance disturbances and vision impairment (e.g., blurred or double vision). These symptoms may completely resolve after a relapse, but some problems may persist.
Dimethyl Fumarate Gedeon Richter appears to inhibit the immune system from causing damage to the brain and spinal cord. This may also help slow down the progression of multiple sclerosis in the future.
Dimethyl Fumarate Gedeon Richter may have a negative effect on white blood cell countand kidney and liver function. Before starting treatment with Dimethyl Fumarate Gedeon Richter, your doctor will check your white blood cell count and ensure that your kidneys and liver are functioning properly. These tests will be performed periodically during treatment. If your white blood cell count decreases during treatment, your doctor may consider additional tests or discontinuation of treatment.
Before taking Dimethyl Fumarate Gedeon Richter, discuss with your doctorif you have:
During treatment with Dimethyl Fumarate Gedeon Richter, shingles (herpes zoster) may occur. In some cases, severe complications have occurred. If you suspect any symptoms of shingles inform your doctor immediately.
If your multiple sclerosis worsens (e.g., you experience weakness or vision disturbances) or you develop new symptoms, you should contact your doctor immediately, as these may be symptoms of a rare brain infection called PML. PML is a serious disease that can lead to severe disability or death.
During treatment with a medicine containing dimethyl fumarate in combination with other fumaric acid esters used to treat psoriasis (a skin disease), rare but serious kidney disorders called Fanconi syndrome have been reported. If you notice that you are urinating more, feel thirstier, and drink more than usual, your muscles seem weaker, you have a fracture, or you simply feel unwell, you should see your doctor as soon as possible to investigate these symptoms.
This medicine should not be given to children under 13 years of age, as there is limited data available for this age group.
Tell your doctor or pharmacistabout all medicines you are taking or have recently taken, and about any medicines you plan to take, especially:
Avoid consuming high-percentage alcoholic beverages (over 30% alcohol by volume, e.g., spirits) in excess of 50 mL within 1 hour of taking Dimethyl Fumarate Gedeon Richter, due to the risk of interaction between alcohol and this medicine. This may lead to stomach upset ( gastritis), especially in people prone to this disease.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
There is limited data on the use of this medicine in pregnant women. Dimethyl Fumarate Gedeon Richter should not be used during pregnancy unless your doctor has discussed it with you and the use of the medicine is necessary.
Breastfeeding
It is not known whether the active substance of Dimethyl Fumarate Gedeon Richter passes into human milk. Your doctor will advise whether to stop breastfeeding or stop taking Dimethyl Fumarate Gedeon Richter. The decision will be based on the assessment of the benefit to the baby from breastfeeding compared to the benefit to the patient from treatment.
Dimethyl Fumarate Gedeon Richter is unlikely to affect your ability to drive or use machines.
This medicine contains less than 1 mmol (23 mg) of sodium per capsule, which is considered to be "sodium-free".
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor.
This initial dose should be taken for the first 7 days, and then the recommended dose should be taken.
Dimethyl Fumarate Gedeon Richter should be taken orally.
Swallow each capsule whole, with water. The capsules should not be divided, crushed, dissolved, sucked, or chewed, as this may increase certain side effects.
Dimethyl Fumarate Gedeon Richter should be taken with food– this will help alleviate very common side effects (listed in section 4).
If you take more capsules than recommended inform your doctor immediately. Side effects similar to those described below in section 4 may occur.
Do not take a double doseto make up for a missed dose.
A missed dose can be taken later, provided that a 4-hour interval is maintained before the next dose. Otherwise, wait until the planned time for the next dose.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Dimethyl fumarate may decrease the number of lymphocytes, a type of white blood cell. A low white blood cell count can increase the risk of infections, including a rare brain infection called progressive multifocal leukoencephalopathy (PML). PML can lead to severe disability or death. PML has been reported after 1 to 5 years of treatment, so your doctor should monitor your white blood cell count throughout treatment, and you should be aware of the symptoms described below, which may indicate PML. The risk of PML may be higher if you have previously taken medicines that affect the immune system.
Symptoms of PML may resemble a relapse of multiple sclerosis. They include weakness or increased weakness on one side of the body; coordination disturbances; vision disturbances, changes in thinking or memory; confusion (disorientation) or personality changes, or speech and communication difficulties lasting more than a few days. Therefore, if you experience a worsening of your multiple sclerosis symptoms or the development of new symptoms while taking Dimethyl Fumarate Gedeon Richter, you should contact your doctor as soon as possible. You should also discuss your treatment with your partner or caregivers and inform them about your treatment. You may not be aware of the symptoms.
The frequency of severe allergic reactions cannot be estimated from the available data (frequency not known).
A very common side effect is sudden flushing of the skin of the face or body ( flushing). If flushing is accompanied by a red rash or hives andany of the following symptoms:
it may indicate a severe allergic reaction ( anaphylaxis).
Very common(may affect more than 1 in 10 people):
During treatment with dimethyl fumarate, increased production of ketone bodies (substances normally produced in the body) is very commonly found in urine tests.
Ask your doctorhow to deal with side effects. Your doctor may reduce the dose of the medicine. Do not reduce the dose yourself unless your doctor advises you to do so.
Common(may affect up to 1 in 10 people):
Side effects that may cause abnormal blood or urine test results
Uncommon(may affect up to 1 in 100 people):
Frequency not known(frequency cannot be estimated from the available data):
The above side effects also apply to children and adolescents.
Some side effects have been reported more frequently in children and adolescents than in adults, e.g., headache, abdominal pain or stomach cramps, vomiting, sore throat, cough, and painful menstruation.
If you experience any side effects, including those not listed in this leaflet, please inform your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products,
Aleje Jerozolimskie 181C
02-222 Warsaw
tel.: + 48 22 49 21 301
fax: + 48 22 49 21 309
website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after "EXP". The expiry date refers to the last day of that month.
Do not store above 30°C.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
The active substance is dimethyl fumarate.
Dimethyl Fumarate Gedeon Richter, 120 mg: each capsule contains 120 mg of dimethyl fumarate.
Dimethyl Fumarate Gedeon Richter, 240 mg: each capsule contains 240 mg of dimethyl fumarate.
Other ingredientsare croscarmellose sodium, siliconized microcrystalline cellulose (microcrystalline cellulose, colloidal anhydrous silica), colloidal anhydrous silica, magnesium stearate, methacrylic acid and methyl methacrylate copolymer (1:1), triethyl citrate, methacrylic acid and ethyl acrylate copolymer (1:1) dispersion 30%, micronized talc, simethicone, gelatin, titanium dioxide (E171), yellow iron oxide (E172), brilliant blue FCF (E133), shellac, black iron oxide (E172), propylene glycol (E1520), and concentrated ammonia solution (E 527).
Dimethyl Fumarate Gedeon Richter, 120 mg, gastro-resistant hard capsules are opaque, dark green ( "cap" ) - white ( "body" ), with black printing "120". The capsule size is No. 1 (length approximately 19.4 mm). The capsule contents are white microtablets.
Dimethyl Fumarate Gedeon Richter, 240 mg, gastro-resistant hard capsules are opaque, dark green ( "cap and body" ), with black printing "240". The capsule size is No. 00 (length approximately 23.3 mm). The capsule contents are white microtablets.
The capsules are packaged in white, opaque PVC/PE/PVDC/Aluminum blister packs.
The blisters are packaged in a folded cardboard box.
Pack sizes:
Dimethyl Fumarate Gedeon Richter, 120 mg, gastro-resistant hard capsules
Cardboard box containing 14 gastro-resistant hard capsules.
Dimethyl Fumarate Gedeon Richter, 240 mg, gastro-resistant hard capsules
Cardboard box containing 56 or 168 gastro-resistant hard capsules.
Not all pack sizes may be marketed.
Gedeon Richter Polska Sp. z o.o.
ul. Ks. J. Poniatowskiego 5
05-825 Grodzisk Mazowiecki
Poland
Gedeon Richter Polska Sp. z o.o.
ul. Ks. J. Poniatowskiego 5
05-825 Grodzisk Mazowiecki
Poland
Gedeon Richter Plc.
1103 Budapest
Gyömrői út 19-21
Hungary
Bulgaria
Диметилфумарат Гедеон Рихтер 120 mg, 240 mg, стомашно-устойчиви твърди капсули
Czech Republic Dimethyl Fumarate Gedeon Richter
Estonia
Dimethyl Fumarate Gedeon Richter
Lithuania
Dimethyl Fumarate Gedeon Richter 120 mg, 240 mg skrandyje neirios kietosios kapsulės
Latvia
Dimethyl Fumarate Gedeon Richter 120 mg, 240 mg zarnās šķīstošās cietās kapsulas
Poland
Dimethyl Fumarate Gedeon Richter
Romania
Dimetil fumarat Gedeon Richter 120 mg, 240 mg capsule gastrorezistente
Slovakia
Dimethyl Fumarate Gedeon Richter 120 mg, 240 mg tvrdé gastrorezistentné kapsuly
Hungary
Dimethyl Fumarate Gedeon Richter 120 mg, 240 mg gyomornedv-ellenálló kemény kapszula
To obtain more detailed information on this medicine, please contact:
Gedeon Richter Polska Sp. z o.o.
Medical Department
ul. Ks. J. Poniatowskiego 5
05-825 Grodzisk Mazowiecki
tel.: +48 (22) 755 96 48
[email protected]
The best alternatives with the same active ingredient and therapeutic effect.